➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Baxter
Moodys
Medtronic
Express Scripts

Last Updated: September 28, 2020

DrugPatentWatch Database Preview

Patent: 10,435,472

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,435,472
Title:Method of treating bone metastasis diseases, medicaments therefore, and a method of predicting the clinical outcome of treating bone metastasis diseases
Abstract: The instant invention provides for a new method of treating bone metastasis diseases in subjects, wherein said method preferably depends on whether the subject shows certain specific proteins levels in one or more body fluids prior to or during treatment, wherein said treatment comprises the administration of at least one pan .alpha.v integrin inhibitor to a subject, a medicament for use in said new methods, and a method of predicting the outcome of a treatment with at least one pan .alpha.v integrin inhibitor based on said specific protein levels in one or more body fluids of the subject.
Inventor(s): Straub; Josef (Seeheim-Jugenheim, DE), Staub; Eike (Darmstadt, DE)
Assignee: Merck Patent GmbH (Darmstadt, DE)
Application Number:15/511,959
Patent Claims:see list of patent claims

Details for Patent 10,435,472

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Dendreon Pharmaceuticals Llc PROVENGE sipuleucel-t INJECTION 125197 001 2010-04-29   Start Trial Merck Patent GmbH (Darmstadt, DE) 2034-09-17 search
Dendreon Pharmaceuticals Llc PROVENGE sipuleucel-t INJECTION 125197 1 2010-04-29   Start Trial Merck Patent GmbH (Darmstadt, DE) 2034-09-17 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
Baxter
Express Scripts
Mallinckrodt
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.